Chief Accounting Officer
Whitehawk Therapeutics, Inc. (WHWK)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2021-11-28–present
Recorded roles and earnings-call appearances connecting this person to public companies.
CFO, CEO, Chief Accounting Officer
2021-11-28–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Whitehawk Therapeutics, Inc. (WHWK) | Chief Financial Officer | $501,561 | $2,121,941 |
| 2024 | Whitehawk Therapeutics, Inc. (WHWK) | Chief Financial Officer | $483,407 | $807,929 |
| 2023 | Whitehawk Therapeutics, Inc. (WHWK) | Chief Financial Officer | $469,328 | $1,971,183 |
| 2022 | Whitehawk Therapeutics, Inc. (WHWK) | Chief Financial Officer and Former Interim President and Chief Executive Officer | $456,870 | $1,504,666 |
| 2021 | Whitehawk Therapeutics, Inc. (WHWK) | Chief Financial Officer | $75,000 | $4,091,590 |
Earnings-call appearances and filed executive appointments or departures, newest first.
